Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
作者信息
Gledhill R M, Norman M R
出版信息
Br J Cancer. 1981 Sep;44(3):467-71. doi: 10.1038/bjc.1981.208.
Abstract
摘要
相似文献
1
Antagonism of drugs used in leukaemia therapy to the killing of human lymphoblastoid cells by steroid.
Br J Cancer. 1981 Sep;44(3):467-71. doi: 10.1038/bjc.1981.208.
2
Inhibition by chemotherapeutic agents of human bone marrow progenitor cells and clonogenic cells of a lymphoblastic cell line.
Eur J Cancer (1965). 1981 May;17(5):519-26. doi: 10.1016/0014-2964(81)90053-0.
3
Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
Br J Cancer. 1983 May;47(5):649-57. doi: 10.1038/bjc.1983.103.
4
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity.
Am J Pediatr Hematol Oncol. 1988 Winter;10(4):288-91. doi: 10.1097/00043426-198824000-00003.
5
The effect of cytotoxic drugs on neutrophil phagocytosis in vitro and in patients with acute myelogenous leukaemia.
Br J Haematol. 1976 Jan;32(1):21-7. doi: 10.1111/j.1365-2141.1976.tb01871.x.
6
Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
Exp Hematol. 2011 Jul;39(7):741-50. doi: 10.1016/j.exphem.2011.04.001. Epub 2011 Apr 9.
7
[Kinetic effect of cytostatic drugs on the generation cycle of human leukaemic blast cells in vivo. A review].
Ugeskr Laeger. 1974 Mar 25;136(13):695-703.
8
Two dimensional view of combination chemotherapy in vitro.
Am J Hematol. 1978;4(1):35-46. doi: 10.1002/ajh.2830040106.
9
Cell kinetics and practical consequences for therapy of acute leukemia.
N Engl J Med. 1975 Aug 21;293(8):389-93. doi: 10.1056/NEJM197508212930807.
10
[Biochemistry of antileukemic drugs].
Schweiz Med Wochenschr. 1970 Feb 14;100(7):310-4.
引用本文的文献
1
Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.
Br J Cancer. 1984 Mar;49(3):363-6. doi: 10.1038/bjc.1984.57.
2
Synergistic killing of human leukaemic lymphoblasts by glucocorticoids and cytosine arabinoside.
Br J Cancer. 1983 May;47(5):649-57. doi: 10.1038/bjc.1983.103.
3
Mode of cell death induced in human lymphoid cells by high and low doses of glucocorticoid.
Br J Cancer. 1983 Apr;47(4):477-86. doi: 10.1038/bjc.1983.77.
本文引用的文献
1
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.
Cancer. 1965 Apr;18:522-9. doi: 10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j.
2
Correlation of cytotoxicity with incorporation of ara-C into DNA.
J Biol Chem. 1980 Oct 10;255(19):8997-900.
3
Effect of feeder cell-released substances on the survival of clonogenic 9L cells after treatment with antimetabolites.
Cancer Res. 1980 Sep;40(9):3202-5.
4
The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.
Cancer Res. 1970 Nov;30(11):2627-35.
5
Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.
J Biol Chem. 1968 Oct 10;243(19):5007-17.
6
Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.
Cancer Res. 1974 Apr;34(4):733-7.
7
Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.
Cancer Res. 1975 Oct;35(10):2872-8.
8
9
Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line.
J Cell Physiol. 1979 Feb;98(2):267-78. doi: 10.1002/jcp.1040980203.
10
Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine.
Cancer Res. 1979 Apr;39(4):1418-24.
Zotero 插件